所述对本发明有效的药物组合物含有对胞外水解有增强抗性的P2Y受体激动药，如二核苷酸多磷酸化合物。
The pharmaceutical composition useful in this invention comprises a P2Y receptor agonist with enhanced resistance to extracellular hydrolysis, such as dinucleoside polyphosphate compounds.
利拉鲁肽是一种GLP - 1受体激动剂，这类药可在用餐后促使胰腺分泌更多的胰岛素。
Victoza is in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists that help the pancreas make more insulin after eating a meal.
利拉鲁肽是一种GLP - 1受体激动剂，这类药可在用餐后促使胰腺分泌更多的胰岛素。
Victoza is in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists that help the pancreas make more insulin after eating a meal.
应用推荐